Longevity
Ageing research, healthy years of life and what science knows about a long life.
-

Medicine in 25 Years: Healthcare for a Society of the Very Old (2051)
Part 4 of the series “The Future of Medicine”: by 2050, up to 9.8 million people in Germany could be aged 80…
-
First in Humans: Cellular Rejuvenation by Gene Therapy Begins in the Eye
With ER-100, a gene therapy intended to epigenetically “reset” ageing nerve cells in the eye is being tested in humans for the…
-
One Injection, Around 20 Per Cent Longer Life: FGF21 Gene Therapy Rejuvenates Old Mice
Researchers in Barcelona gave old mice a one-off gene therapy injected into the muscle that releases the metabolic hormone FGF21. On average,…
-
Gene Editing Against Heart Attacks: One Infusion Lowers LDL Cholesterol by up to 62 Per Cent
With the base editor VERVE-102, Eli Lilly permanently switches off the cholesterol gene PCSK9 in the liver. New trial data show a…
-
Semaglutide Extends the Lives of Old Mice – Apparently Not Just by Reducing Food Intake
A UC Berkeley study published in Nature shows that old mice given semaglutide lived longer and remained physically and mentally fitter. Calorie…
-
Does Semaglutide Slow the Biological Clock? First Evidence from a Randomised Trial
In a placebo-controlled trial of 108 people with HIV, the active ingredient in Ozempic and Wegovy slowed the pace of biological ageing…
-
435 Million Dollars for Younger Liver Cells: NewLimit Bets on mRNA Reprogramming
The Californian start-up NewLimit has closed one of the largest funding rounds in the longevity sector. It aims to rejuvenate liver cells…
-
Klotho as an mRNA Therapy: First Trial of the “Longevity Protein” in Healthy Adults
The start-up Klothea Bio is testing an mRNA therapy intended to raise blood levels of Klotho. The small trial is taking place…
-
Rejuvenation in the Brain: Reprogramming Gene Therapy for Alzheimer’s Moves Closer
The start-up YouthBio Therapeutics wants to rejuvenate nerve cells epigenetically using Yamanaka factors. The FDA has judged the preclinical data sufficient for…
-
Dogs Lead the Way: The First Longevity Drug and Gene Therapies for Older Dogs
The FDA has completed another review step for LOY-002, a tablet intended to extend the healthy life of older dogs. In parallel,…
